• Driving value from genomics

    Hilary Thomas considers the progress and challenges in reaping the benefits of genomics

  • Pitch perfect

    A perfect pitch process benefits pharma as much as the agencies involved. Mike Dixon, chief executive of the Healthcare Communications Association, discusses two initiatives trying to help identify best practice guidance for all stakeholders in the pitch process

  • Transformational change

    The decade ahead for UK pharma – a shot in the arm or bitter pill to swallow?

News

View all

Web Exclusives

View all
Thumbnail image for After February 29

After February 29

Rare Disease Day is a fixture in the calendar not only for affected patients and families, and patient advocacy organisations, but also the myriad of other stakeholders that make up the rare disease ecosystem

Thumbnail image for Unlocking value

Unlocking value

How cell and gene therapies are driving new deals in life sciences

Thumbnail image for A NICE transformation?

A NICE transformation?

Will the NICE Review of Methods and Processes pave the way to HTA reform? As we wait for the consultation, Nicola Boyd argues that we should be realistic about what the Review will deliver

Thumbnail image for A changing landscape

A changing landscape

Gustaf Duhs considers the legal issues surrounding the rapidly expanding field of digital health

Thumbnail image for Smart People: Stephen Nabarro

Smart People: Stephen Nabarro

Stephen Nabarro, head of clinical operations and data management at Cancer Research UK Centre for Drug Development, talks to PharmaTimes about his role in cancer research

Thumbnail image for Pitch perfect

Pitch perfect

A perfect pitch process benefits pharma as much as the agencies involved. Mike Dixon, chief executive of the Healthcare Communications Association, discusses two initiatives trying to help identify best practice guidance for all stakeholders in the pitch process

Thought Leadership

View all
Thumbnail image for Creating common endeavours

Creating common endeavours

Conclusio’s Johnny Skillicorn-Aston and James Roach consider the true meaning of patient-centricity in clinical trials

Thumbnail image for Deep impact

Deep impact

The NHS Long Term Plan and what the industry response should be

Thumbnail image for The Value Exchange

The Value Exchange

Simon Grime, of Wilmington Healthcare, explains the principles of exchanging value with customers to gain trust and consent

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download